Bayshore Pharmaceuticals
  • About Us
  • Our Business
  • Products
  • Contact
  • LinkedIn

News

Visit Us at NACDS TSE 2022: Booth 1710

June 2, 2022 By Brittney Guida In Announcement /  

NEW PRODUCTS NOW AVAILABLE-Nov 2021

November 2, 2021 By Brittney Guida In Product Updates /  

Bayshore Pharmaceuticals as featured on Inside The Blueprint Local NY

October 23, 2021 By Brittney Guida In Announcement /  

Beximco Pharmaceuticals- Setting The Bar High for Generic Medicines

September 22, 2021 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals Granted Etodolac ANDA Approvals

December 22, 2020 By Brittney Guida In Announcement /  

Beximco Pharma receives US FDA approval for Flecainide Acetate Tabs

September 22, 2020 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

August 19, 2020 By Brittney Guida In Announcement /  

NACDS 2020, San Diego, August 8 – 10, Booth 2006

January 1, 2020 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals Announces Launch of Carvedilol Tablets

November 16, 2016 By mark.moshier In Announcement /  

NEW PRODUCT INTRODUCTION: Carvedilol USP The 1st FDA Approved pharmaceutical product manufactured in Bangladesh. Bayshore launches immediately via Strategic Marketing collaboration with Beximco Pharmaceuticals.

October 31, 2016 By contemplate In Uncategorized /  

Posts navigation

1 2

Bayshore Pharmaceuticals

© Bayshore Pharmaceuticals. All rights reserved. | Admin | Site by Contemplate Design